Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
Crossref DOI link: https://doi.org/10.1007/s00198-021-06268-9
Published Online: 2022-01-21
Published Print: 2022-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wan, Y.
Zeng, F.
Tan, H.
Lu, Y.
Zhang, Y.
Zhao, L.
You, R.
Text and Data Mining valid from 2022-01-21
Version of Record valid from 2022-01-21
Article History
Received: 20 September 2021
Accepted: 8 December 2021
First Online: 21 January 2022
Declarations
:
: None.